rs60275734

Variant names:

• chr16-1211258-C-A
• rs60275734
• NM_021098.3:c.4314C>A

Your query was ambiguous. Multiple possible variants found:

• chr16-1211258-C-A
• chr16-1211258-C-T

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1 PM2

The NM_021098.3(CACNA1H):​c.4314C>A​(p.Cys1438*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.

• Frequency: Genomes: not found (cov: 35)
• Consequence: CACNA1H NM_021098.3 stop_gained
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: -1.55

Genes affected

CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Pathogenic. Variant got 10 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CACNA1H	NM_021098.3	c.4314C>A	p.Cys1438*	stop_gained	Exon 22 of 35	ENST00000348261.11	NP_066921.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CACNA1H	ENST00000348261.11	c.4314C>A	p.Cys1438*	stop_gained	Exon 22 of 35	1	NM_021098.3	ENSP00000334198.7
CACNA1H	ENST00000565831.6	c.4314C>A	p.Cys1438*	stop_gained	Exon 21 of 33	1		ENSP00000455840.1
CACNA1H	ENST00000638323.1	c.4275C>A	p.Cys1425*	stop_gained	Exon 22 of 35	5		ENSP00000492267.1
CACNA1H	ENST00000569107.5	c.537C>A	p.Cys179*	stop_gained	Exon 5 of 17	1		ENSP00000454990.2
CACNA1H	ENST00000564231.5	c.537C>A	p.Cys179*	stop_gained	Exon 5 of 18	1		ENSP00000457555.2
CACNA1H	ENST00000562079.5	c.537C>A	p.Cys179*	stop_gained	Exon 5 of 17	1		ENSP00000454581.2
CACNA1H	ENST00000637236.2	n.*284C>A		non_coding_transcript_exon_variant	Exon 6 of 6	5		ENSP00000492650.2
CACNA1H	ENST00000639478.1	n.4314C>A		non_coding_transcript_exon_variant	Exon 22 of 35	5		ENSP00000491945.1
CACNA1H	ENST00000640028.1	n.*2227C>A		non_coding_transcript_exon_variant	Exon 22 of 35	5		ENSP00000491488.1
CACNA1H	ENST00000637236.2	n.*284C>A		3_prime_UTR_variant	Exon 6 of 6	5		ENSP00000492650.2
CACNA1H	ENST00000640028.1	n.*2227C>A		3_prime_UTR_variant	Exon 22 of 35	5		ENSP00000491488.1

Frequencies

GnomAD3 genomes Cov.: 35

GnomAD4 exome Cov.: 60

GnomAD4 genome Cov.: 35

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1

Jun 11, 2023

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys1438*) in the CACNA1H gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA1H cause disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.51	D
BayesDel_noAF	Pathogenic	0.50
CADD	Pathogenic	35
DANN	Uncertain	0.99
Eigen	Benign	0.037
Eigen_PC	Benign	-0.26
FATHMM_MKL	Benign	0.26	N
Vest4		0.87
GERP RS		-2.5

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.060		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs60275734; hg19: chr16-1261258;